Skip to main content
. 2009 Jan;99(1):152–159. doi: 10.2105/AJPH.2007.117010

TABLE 2.

Examination-Based Prevalence, Awareness, and Control of Selected Conditions Among Adults 20 Years or Older: NYC-HANES, 2004, and NHANES, 2003–2004

NYC-HANES 2004
NHANES 2003–2004
Health Outcome No. % (95% CI) No. % (95% CI)
Chronic conditions
Hypertension 1975 25.6 (23.4, 27.8) 4401 30.6a (28.4, 33.0)
    Undiagnosedb 389 25.0 (18.9, 32.4) 1633 32.9 (26.4, 40.1)
    Controlledb 389 43.6 (37.6, 49.9) 1633 36.5 (29.7, 43.8)
Hypercholesterolemia 1768 25.4 (22.9, 28.1) 4475 27.3 (26.0, 28.7)
    Undiagnosedc 359 37.2 (31.3, 43.5) 1329 40.5 (35.1, 46.3)
    Controlledc 359 29.6 (25.1, 34.4) 1329 27.9 (24.6, 31.6)
Diabetes 1336 12.5 (10.3, 15.1 1977 10.4 (8.7, 12.3)
    Undiagnosedd 131 27.9 (19.2, 38.6 254 29.4 (18.6, 43.3)
    Controlledd 130 54.6 (42.5, 66.1) 245 55.6 (42.2, 68.2)
Weight
Underweight (BMI < 18.5 kg/m2) 1915 1.6 (1.2, 2.2) 4227 1.7 (1.4, 2.1)
Normal weight (BMI 18.5–24.9 kg/m2) 1915 36.6 (33.6, 39.7) 4227 32.5a (30.0, 35.0)
Overweight (BMI 25.0–29.9 kg/m2) 1915 36.1 (33.4, 38.9) 4227 34.3 (32.1, 36.6)
Obese (BMI > 30 kg/m2) 1915 25.6 (23.2, 28.3) 4227 31.5a (29.0, 34.2)
Infectious diseases
HSV-2
    Aged ≥ 20 years 1780 27.9 (24.8, 31.2) NAe NAe
    Aged 20–49 years 1281 23.6 (20.4, 27.1) 2227 19.2a (17.1, 21.5)
HCV 1786 2.3 (1.5, 3.4) 4460 1.9 (1.3, 2.7)
Environmental exposures
Cotinine (≥ 0.050 ng/mL, nonsmokersf) 1330 56.7 (53.6, 59.7) 3285 44.9a (38.1, 51.8)
Leadg 1811 1.79 (1.73, 1.86) 4525 1.52 (1.45, 1.60)
Mercuryg 1811 2.73 (2.58, 2.89) 4525 0.98a (0.86, 1.11)
Cadmiumg 1811 0.77 (0.75, 0.80) 4525 0.38a (0.36, 0.40)

Note. NYC-HANES = New York City Health and Nutrition Examination Survey; NHANES = National Health and Nutrition Examination Survey; CI = confidence interval; BMI = body mass index; HSV-2 = herpes simplex virus 2; HCV = hepatitis C virus. All prevalence estimates were age-adjusted to the 2000 US standard population.

a

Significantly different from NYC-HANES estimate (P < .05).

b

Among individuals with examination-based hypertension.

c

Among individuals with examination-based hypercholesterolemia.

d

Among individuals with examination-based diabetes.

e

Not available; tested only for participants aged 14 to 49 years.

f

Nonsmokers defined as participants with serum cotinine concentrations at or below 10 ng/mL.

g

Values presented as geometric means, not percentages.